1 |
Watanabe J, Hayashi S, Nakachi K, et al (1990). PstI and RsaI RFLPs in complete linkage disequilibrium at the CYP2E gene. Nucleic Acids Res, 18, 7194.
|
2 |
Ye W, Chen S, Chen Q, Zhang D, Cai X (2006). Association of CYP2E1 polymorphism and serum selenium level with risk of human lung cancer. Tumor, 26, 450-2.
|
3 |
Zhan P, Wang J, Zhang Y, et al (2010). CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians. Lung Cancer, 69, 19-25.
DOI
ScienceOn
|
4 |
Zhao P, Dai M, Chen W, Li N (2010). Cancer trends in China. Jpn J Clin Oncol, 40, 281-5.
DOI
ScienceOn
|
5 |
Zhou HF, Feng X, Zheng BS, Qian J, He W (2013). A meta-analysis of the relationship between glutathione S-transferase T1 null/presence gene polymorphism and the risk of lung cancer including 31802 subjects. Mol Biol Rep, 40, 5713-21.
DOI
ScienceOn
|
6 |
Zou L, Lv B, Zhang X, et al (2004). Effect of CYP2E1 polymorphism on DNA stability and lung cancer susceptibility. J Environmental Occupational Medicine, 21, 81-3.
|
7 |
Wang F, Yang H (2010a). Meta-analysis of relationship between the polymorphism of cytochrome P4502E1 RsaI/PstI and susceptibility of lung cancer in Chinese populations. Chinese J Prev Med, 44, 553-4.
|
8 |
Su XL, Bin B, Cui HW, Ran MR (2011). Cytochrome P450 2E1 RsaI/PstI and DraI polymorphisms are risk factors for lung cancer in Mongolian and Han populations in Inner Mongolia. Chin J Cancer Res, 23, 107-11.
DOI
ScienceOn
|
9 |
Tan W, Wu J, Tang H, Lin D (2001). Expression of cytochrome P4502E1 in human liver: Relationship between genotype and phenotype in Chinese. Sci China C Life Sci, 44, 356-64.
DOI
ScienceOn
|
10 |
Ulusoy G, Arinc E, Adali O (2007). Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population. Arch Toxicol, 81, 711-8.
DOI
ScienceOn
|
11 |
Wang D, Chen S, Wang B, Zhou W (2006). A case-control study on the impact of cytochrome P450 2E1 and 1A1 gene polymorphisms on the risk of lung cancer of the Han nationality in Guangzhou district. Chin J Lung Cancer, 9, 497-501.
|
12 |
Wang H, Song K, Chen Z, Yu Y (2013). Poor metabolizers at the cytochrome P450 2C19 loci is at increased risk of developing cancer in Asian populations. PLoS One, 8, 73126.
DOI
|
13 |
Wang J, Deng Y, Li L, et al (2003). Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case-control study in Chinese population. Cancer Sci, 94, 448-52.
DOI
ScienceOn
|
14 |
Wang Y, Yang H, Li L, et al (2010b). Association between CYP2E1 genetic polymorphisms and lung cancer risk: a meta-analysis. Eur J Cancer, 46, 758-64.
DOI
ScienceOn
|
15 |
Shah PP, Singh AP, Singh M, et al (2008). Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res, 639, 1-10.
DOI
ScienceOn
|
16 |
Phukan RK, Saikia BJ, Borah PK, et al (2014). Role of household exposure, dietary habits and glutathione S-Transferases M1, T1 polymorphisms in susceptibility to lung cancer among women in Mizoram India. Asian Pac J Cancer Prev, 15, 3253-60.
과학기술학회마을
DOI
ScienceOn
|
17 |
Qu Y, Shi Y, Zhang l, et al (1998). Cytochrome P450 2E1 Genetic Polymorphism and Non-smoking Female Lung Cancer Risk. Carcinogenesis Teratogenesis and Mutagenesis, 10, 355-8.
|
18 |
Salanti G, Amountza G, Ntzani EE, Ioannidis JP (2005). Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet, 13, 840-8.
DOI
ScienceOn
|
19 |
Shi Y, Zhou X, Zhou Y, Ren X (2002). Analysis of CYP2E1, GSTM1 genetic polymorphisms in relation to human lung cancer and esophageal carcinoma. J Huazhong Univ Sci Technolog Med Sci, 31, 14-7.
|
20 |
Shields PG, Harris CC (2000). Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol, 18, 2309-15.
DOI
|
21 |
Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.
DOI
ScienceOn
|
22 |
Soya SS, Padmaja N, Adithan C (2005). Genetic polymorphisms of CYP2E1 and GSTP1 in a South Indian population--comparison with North Indians, Caucasians and Chinese. Asian Pac J Cancer Prev, 6, 315-9.
|
23 |
Liu H, Su Y, Chen R, Wei J (2010). Study on the relationship between genetic polymorphism of human cytochrome P450 2E l gene and susceptibility to Xuanwei's lung cancer. J Mod Lab Med, 25, 23-6.
|
24 |
Li Z, Tan W, Shao K, Zhang L, Lin D (2000). Susceptibility to lung cancer in Chinese is associated with genetic polymorphism in cytochrome P4502E1. Chin J Oncol, 22, 5-7.
|
25 |
Liang G, Pu Y, Yin L (2004). Studies of the genes related to lung cancer susceptibility in Nanjing Han population, China. Hereditas, 26, 584-8.
|
26 |
Liu J, Yang XL, Li A, et al (2014). Epidemiological patterns of cancer incidence in southern China: based on 6 population-based cancer registries. Asian Pac J Cancer Prev, 15, 1471-5.
과학기술학회마을
DOI
ScienceOn
|
27 |
Liu Y, Meng XW, Zhou LY, et al (2009). Genetic polymorphism and mRNA levels of cytochrome P450IIE1 and glutathione S-transferase P1 in patients with alcoholic liver disease in different nationalities. Hepatobiliary Pancreat Dis Int, 8, 162-7.
|
28 |
Marchand LL, Wilkinson GR, Wilkens LR (1999). Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone. Cancer Epidemiol Biomarkers Prev, 8, 495-500.
|
29 |
Lucas D, Menez C, Girre C, et al (1995). Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics, 5, 298-304.
DOI
ScienceOn
|
30 |
Luqman M, Javed MM, Daud S, et al (2014). Risk factors for lung cancer in the Pakistani population. Asian Pac J Cancer Prev, 15, 3035-9.
과학기술학회마을
DOI
ScienceOn
|
31 |
Persson I, Johansson I, Lou YC, et al (1999). Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients. Int J Cancer, 81, 325-9.
DOI
|
32 |
Huang Y, Wang Q, Zhu L, Zhang Y (2000). Relationship between cytochrome P450 2E1 Genetic Polymorphism and Lung Cancer in Chinese Han subjects. J Clin Pharmacol, 16, 350-2.
|
33 |
Gu Y, Zhang Z, Zhang S, et al (2007). Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility. Zhonghua Yi Xue Za Zhi, 87, 3064-8.
|
34 |
Guo S, Li X, Gao M, et al (2012). Synergistic association of PTGS2 and CYP2E1 genetic polymorphisms with lung cancer risk in northeastern Chinese. PLoS One, 7, 39814.
DOI
|
35 |
Hayashi S, Watanabe J, Kawajiri K (1991). Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem, 110, 559-65.
DOI
|
36 |
Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
DOI
|
37 |
Li W, Lai B, Zhan X (2004). The relationship between genetic polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer. Chinese J Epidemiol, 25, 1042-5.
|
38 |
Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y (2005). NQO1, MPO, and the risk of lung cancer: a HuGE review. Genet Med, 7, 463-78.
DOI
ScienceOn
|
39 |
Lakkakula S, Maram R, Munirajan AK, et al (2013). Functional PstI/RsaI polymorphisms in the CYP2E1 gene among south Indian populations. Asian Pac J Cancer Prev, 14, 179-82.
과학기술학회마을
DOI
ScienceOn
|
40 |
Li D, Zhou Q, Guo Z, et al (2008). Association between genetic polymorphisms of CYP2E1 and lung cancer susceptibility:a case control study. Journal of Third Military Medical University, 30, 1231-4.
|
41 |
Li W, Yue W, Zhang L, et al (2012). Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are associated with susceptibility and chemotherapy response in non-small-cell lung cancer patients. Lung, 190, 91-8.
DOI
|
42 |
Chen S, Yu S, Chen Q, et al (2002). A case-control study of the impact of CYP2E1 RsaI polymorphism on the risk of lung cancer. J Guangdong College of Pharmacy, 18, 220-4.
|
43 |
Agundez JA (2008). Polymorphisms of human N-acetyltransferases and cancer risk. Curr Drug Metab, 9, 520-31.
DOI
ScienceOn
|
44 |
Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
DOI
ScienceOn
|
45 |
Cao L, Lin J, He B, et al (2013). A regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma. Tumour Biol, DOI 10.1007/s13277-013-1063-x.
DOI
|
46 |
Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
DOI
ScienceOn
|
47 |
DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
DOI
ScienceOn
|
48 |
Wang SL, Lee H, Chen KW, et al (1999). Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population. Lung Cancer, 26, 27-34.
DOI
ScienceOn
|
49 |
Shahriary GM, Galehdari H, Jalali A, et al (2012). CYP2E1*5B, CYP2E1*6, CYP2E1*7B, CYP2E1*2, and CYP2E1*3 allele frequencies in Iranian populations. Asian Pac J Cancer Prev, 13, 6505-10.
과학기술학회마을
DOI
ScienceOn
|
50 |
Liu H, Li HY, Chen HJ, et al (2013). EPHX1 A139G polymorphism and lung cancer risk: a meta-analysis. Tumour Biol, 34, 155-63.
DOI
ScienceOn
|